PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Consumption of Salba-chia (30g/1000kcal/day) for 6 months resulted in greater weight loss compared to an oat bran-based control [PMID:28089080].
Supplementation with 25g ground Salba-chia reduced the blood glucose area under the curve over 120 minutes [PMID:28000689].
A meta-analysis of four RCTs indicated that chia consumption significantly decreases inflammatory markers, specifically C-reactive protein (CRP), interleukin-6 (IL-6), and tumour necrosis factor-alpha (TNF-α) [PMID:39703891].
Systematic reviews indicate potential for improving lipid profiles and blood pressure, though some findings remain inconsistent or lack high-quality evidence [PMID:26545644, PMID:41076614].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36655089 (2023) — Chia seeds (Salvia hispanica L.): A therapeutic weapon in metabolic disorders. · Food science & nutrition
- 2.PMID: 28646829 (2017) — Chia seeds (Salvia hispanica): health promoting properties and therapeutic applications – a review. · Roczniki Panstwowego Zakladu Higieny
- 3.PMID: 30000875 (2006) — Nutritional and Functional New Perspectives and Potential Health Benefits of Quinoa and Chia Seeds. · Antioxidants (Basel, Switzerland)
- 4.PMID: 26319904 (2015) — Chia (Salvia hispanica): A Review of Native Mexican Seed and its Nutritional and Functional Properties. · Advances in food and nutrition research
- 5.PMID: 39703891 (2024) — Chia seed supplementation and inflammatory biomarkers: a systematic review and meta-analysis.